Costa Rica vs Djibouti: HIV-positive TB patients on ART (antiretroviral therapy)
Costa Rica
72.0%
in 2024
Djibouti
71.0%
in 2024
Costa Rica rank
123rd
Djibouti rank
124th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Costa Rica
- Djibouti
How they compare
Costa Rica currently reports 72.0% against 71.0% in Djibouti, a difference of 1.0%.
Across all 13 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 123rd and Djibouti ranks 124th of 144 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Djibouti | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.0% | 18.0% | 58.0% | Costa Rica |
| 2010s | 96.8% | 65.4% | 31.4% | Costa Rica |
| 2020s | 90.7% | 58.3% | 32.3% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Costa Rica or Djibouti?
- Costa Rica, at 72.0% against 71.0% in Djibouti as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Costa Rica and Djibouti?
- 1.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Djibouti?
- 13 years are reported by both, from 2003 to 2024.
- How do Costa Rica and Djibouti rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Costa Rica ranks 123rd and Djibouti ranks 124th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.